GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (BSP:C1OO34) » Definitions » Beneish M-Score

The Cooper (BSP:C1OO34) Beneish M-Score : -2.47 (As of Jun. 28, 2025)


View and export this data going back to 2020. Start your Free Trial

What is The Cooper Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.47 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for The Cooper's Beneish M-Score or its related term are showing as below:

BSP:C1OO34' s Beneish M-Score Range Over the Past 10 Years
Min: -2.91   Med: -2.55   Max: -1.07
Current: -2.47

During the past 13 years, the highest Beneish M-Score of The Cooper was -1.07. The lowest was -2.91. And the median was -2.55.


The Cooper Beneish M-Score Historical Data

The historical data trend for The Cooper's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Beneish M-Score Chart

The Cooper Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.64 -1.07 -2.64 -2.52 -2.43

The Cooper Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.38 -2.43 -2.43 -2.50 -2.47

Competitive Comparison of The Cooper's Beneish M-Score

For the Medical Instruments & Supplies subindustry, The Cooper's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Cooper's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where The Cooper's Beneish M-Score falls into.


;
;

The Cooper Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of The Cooper for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0382+0.528 * 0.9853+0.404 * 0.9568+0.892 * 1.2328+0.115 * 1.1315
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9579+4.679 * -0.025856-0.327 * 0.9475
=-2.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Apr25) TTM:Last Year (Apr24) TTM:
Total Receivables was R$4,522 Mil.
Revenue was 5803.818 + 5798.715 + 5731.352 + 5559.323 = R$22,893 Mil.
Gross Profit was 3932.329 + 3968.396 + 3813.96 + 3675.539 = R$15,390 Mil.
Total Current Assets was R$12,309 Mil.
Total Assets was R$71,881 Mil.
Property, Plant and Equipment(Net PPE) was R$11,167 Mil.
Depreciation, Depletion and Amortization(DDA) was R$2,089 Mil.
Selling, General, & Admin. Expense(SGA) was R$8,958 Mil.
Total Current Liabilities was R$5,863 Mil.
Long-Term Debt & Capital Lease Obligation was R$14,624 Mil.
Net Income was 507.827 + 626.937 + 661.266 + 580.436 = R$2,376 Mil.
Non Operating Income was -93.227 + -16.229 + -15.758 + -1.663 = R$-127 Mil.
Cash Flow from Operations was 557.046 + 1145.678 + 1508.813 + 1150.338 = R$4,362 Mil.
Total Receivables was R$3,533 Mil.
Revenue was 4835.538 + 4581.795 + 4687.325 + 4465.425 = R$18,570 Mil.
Gross Profit was 3238.056 + 3067.973 + 3066.403 + 2928.305 = R$12,301 Mil.
Total Current Assets was R$9,537 Mil.
Total Assets was R$61,803 Mil.
Property, Plant and Equipment(Net PPE) was R$8,769 Mil.
Depreciation, Depletion and Amortization(DDA) was R$1,903 Mil.
Selling, General, & Admin. Expense(SGA) was R$7,585 Mil.
Total Current Liabilities was R$4,886 Mil.
Long-Term Debt & Capital Lease Obligation was R$13,704 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(4521.801 / 22893.208) / (3533.031 / 18570.083)
=0.197517 / 0.190254
=1.0382

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(12300.737 / 18570.083) / (15390.224 / 22893.208)
=0.662395 / 0.672262
=0.9853

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (12308.866 + 11166.979) / 71880.951) / (1 - (9536.67 + 8768.709) / 61803.162)
=0.673407 / 0.703812
=0.9568

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=22893.208 / 18570.083
=1.2328

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1902.69 / (1902.69 + 8768.709)) / (2088.72 / (2088.72 + 11166.979))
=0.178298 / 0.157571
=1.1315

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(8957.501 / 22893.208) / (7585.096 / 18570.083)
=0.391273 / 0.408458
=0.9579

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((14624.487 + 5862.881) / 71880.951) / ((13703.769 + 4886.325) / 61803.162)
=0.285018 / 0.300795
=0.9475

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(2376.466 - -126.877 - 4361.875) / 71880.951
=-0.025856

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The Cooper has a M-score of -2.34 suggests that the company is unlikely to be a manipulator.


The Cooper Beneish M-Score Related Terms

Thank you for viewing the detailed overview of The Cooper's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


The Cooper Business Description

Traded in Other Exchanges
Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.

The Cooper Headlines

No Headlines